2016

1. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable CT3-4 or N+ rectal cancer: Five-year disease-free survival results of a single-center series

   Clinical Colorectal Cancer, Vol. 15, Núm. 2, pp. 128-134